Sin conexión a internet: se muestra la versión guardada de la página.

Bausch + Lomb Cor…

USUSD
← Al Screener

Bausch + Lomb Corp (TO:BLCO) — Ophthalmic Goods. Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
bausch.com
Relaciones con los Inversores
ir.bausch.com/investor-relations/sec-filings
Sector
Health Care · Ophthalmic Goods
Sede Central
Rochester, Canada
Consejero Delegado
Brenton L. Saunders
Empleados
12 900
Fundada
1853
Acciones en Circulación
357.17 M a 2026-07-22
Capital Flotante
45.55 M
Capitalización Bursátil
6.18 mil M USD
Insiders
87.29%
Inversores Institucionales
11.14%
Industria (SIC)
Ophthalmic Goods
P/E
pérdidas
FCF
137 M USD
Deuda
5.08 mil M USD
34 a. de FCF
Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
NAV
17.86 USD · P/NAV 0.91
Fecha del Balance30.06.2026
Activos13.9 mil M USD
− Pasivos7.42 mil M USD
= Patrimonio Total6.44 mil M USD
− Participaciones No Dominantes68.0 M USD
= NAV (patrimonio de los accionistas de la empresa)6.38 mil M USD
− Fondo de Comercio4.72 mil M USD
− Activos Intangibles3.17 mil M USD
= NAV Tangible−1.52 mil M USD
Acciones357 057 005
NAV por Acción17.86 USD
NAV Tangible por Acción−4.25 USD
Precio de la Acción (BLCO)23.1300 CAD
P/NAV0.91
Historial del NAV
Fecha del BalanceNAVNAV por Acción
30.06.20266.38 mil M USD17.86 USD
31.03.20266.38 mil M USD17.90 USD
31.12.20256.45 mil M USD18.20 USD
30.09.20256.43 mil M USD18.16 USD
30.06.20256.44 mil M USD18.20 USD
31.03.20256.36 mil M USD18.00 USD
31.12.20246.47 mil M USD18.37 USD
30.09.20246.59 mil M USD18.71 USD
Descripción

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksBLCO principalUSD16.66 +3.87%acciones ordinarias
TO Toronto Stock ExchangeBLCO secundariaCAD23.13 -1.62%acciones ordinarias

Precio en 3 Meses

día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Icahn Carl C0.98%3.5 M2026-06-30
Oaktree Capital Manageme…0.96%3.44 M2026-06-30
Deutsche Bank AG0.96%3.42 M2026-06-30
Shaw D.E. & Co., Inc.0.93%3.32 M2026-06-30
Davidson Kempner Capital…0.88%3.16 M2026-06-30
Goldentree Asset Managem…0.74%2.66 M2026-06-30
Price (T.Rowe) Associate…0.6%2.16 M2026-06-30
CASPIAN CAPITAL, LP0.56%2 M2026-06-30
Glenview Capital Managem…0.54%1.92 M2026-06-30
Arrowstreet Capital, Lim…0.38%1.36 M2026-06-30
SAUNDERS BRENT L. (Chief…≈0.35%1.26 M2026-08-05
T. Rowe Price High Yield…0.23%811 2422026-06-30
TR PRICE-Price (T.Rowe)…0.13%454 2202026-06-30
ELDESSOUKY SAM (Chief Fi…≈0.11%407 1302026-03-06
ELDESSOUKY OSAMA A (Chie…≈0.11%393 5272026-08-05
BAILEY AMBROSE ROBERT DO…≈0.07%264 2412026-08-05
T. ROWE PRICE Inst. INCO…0.06%214 8282026-06-30
T. ROWE PRICE Intl Fd.S,…0.06%204 4912026-06-30
HASHAD YEHIA (Officer)≈0.05%187 3502026-08-05
Unified Series Trust-BAL…0.04%147 8372026-06-30
Gabelli Healthcare & Wel…0.04%144 0002026-09-30
BONNEFOY LUC (Officer)≈0.03%103 8012026-08-05
STEWART ANDREW JUDE (Off…≈0.03%103 2112026-08-05
ROBERTSON RUSSEL C (Dire…≈0.03%94 2602026-05-26
PAULSON JOHN A. (Directo…≈0.03%89 8232026-05-26
BERNIER NATHALIE D (Dire…≈0.02%85 5052026-05-26
Gabelli Dividend & Incom…0.02%75 0002026-09-30
T. Rowe Price Credit Opp…0.01%52 9002026-06-30
Gabelli Asset Fund-The G…0.01%45 0002026-09-30
Fidelity Rutland Square…0.01%43 4882026-08-31